0.82
-0.0074(-0.90%)
Currency In USD
| Previous Close | 0.83 |
| Open | 0.82 |
| Day High | 0.82 |
| Day Low | 0.78 |
| 52-Week High | 6.89 |
| 52-Week Low | 0.56 |
| Volume | 558,462 |
| Average Volume | 2.6M |
| Market Cap | 13.52M |
| PE | -20.44 |
| EPS | -0.04 |
| Moving Average 50 Days | 0.73 |
| Moving Average 200 Days | 2.09 |
| Change | -0.01 |
If you invested $1000 in iBio, Inc. (IBIO) 10 years ago, it would be worth $0.22 as of August 30, 2025 at a share price of $0.818. Whereas If you bought $1000 worth of iBio, Inc. (IBIO) shares 5 years ago, it would be worth $0.78 as of August 30, 2025 at a share price of $0.818.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iBio Announces Closing of $50 Million Public Offering
GlobeNewswire Inc.
Aug 25, 2025 11:00 AM GMT
Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Brid
iBio Announces Pricing of $50 Million Public Offering
GlobeNewswire Inc.
Aug 19, 2025 12:01 PM GMT
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase 7
iBio Announces Proposed Public Offering
GlobeNewswire Inc.
Aug 18, 2025 8:01 PM GMT
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced it has commenced an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase